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the available photon energies in our TrueBeam: 6MV, 15MV, 
6MV FFF and 10MV FFF. Geometrical checks were measured 
only for the 6MV beam. 
 
Results: In all our measurements we found that the results 
were within the established tolerances. The value of the 
isocenter’s size is, in our case, 0.27 mm, very close to that 
obtained by Clivio et al. for the same energy, 0.34 mm. The 
values of the 6MV beam center shift, MV imager projection 
offset and absolute gantry positioning are the same that the 
ones obtained in the mentioned study: 0.04 mm, 0.17 mm 
and -0.09° respectively. For that same energy the offset of 
the collimator rotation is, in our case, 0.15°, while the one 
reported in the study is 0.17°, and the kV imager projection 
offset, 0.24 mm versus 0.32 mm. The output change in our 
TrueBeam varies from -0.58% for the 10MV FFF beam to -
0.50% for the 6MV beam. In the study these values range from 
0.06% for their 15 MV beam to 0.24% for their 6MV FFF beam. 
 
Conclusion: Our TrueBeam MPC results were compared with 
those obtained by Clivio et al. at their institution. They show 
great agreement with those reported in their study. We have 
established MPC tool measurements as part of our routine 
daily QA. 
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Purpose or Objective: To evaluate the dosimetric and 
optimization algorithm accuracy of a newly released version 
13.5 of the Eclipse treatment planning system (TPS) prior to 
upgrade, utilizing the recently published AAPM Medical 
Physics Practice Guideline (MPPG), “Commissioning and QA of 
treatment planning dose calculations”. 
 
Material and Method: Eclipse V13.5 includes many novel 
features, such as contouring tool enhancements, streamlined 
4D CT contouring, new physical materials for the AcurosXB 
(AXB) dose algorithm, and faster optimization engines. MPPG 
phantom tests were performed to validate both static and 
dynamic beams in both homo- and hetero- generous material. 
Additionally, 54 patient plans were re-calculated in V13.5 
with the same beam parameters, monitor units, and dose 
algorithms in order to examine algorithm difference. A dose-
difference plan was created by subtracting the dose 
calculated in V13.5 from V11 and evaluated in 3D dose 
display. Those re-calculated patient plans included a variety 
of treatment sites, energies, and techniques. However, the 
new Photon Optimizer (PO) algorithm was developed in V13.5 
to replace the previous Dose Volume Optimizer (DVO) in IMRT 
and Progressive Resolution Optimizer (PRO) in VMAT. In order 
to compare the PO and DVO/PRO optimizers, 25 IMRT/VMAT 
clinical plans were re-optimized with PO using the same 
objectives, prescriptions, and number of iterations. The plan 
quality and optimization time were examined. 
 
Results: Dose differences for all clinical cases and MPPG 
phantom tests in-field and in homogeneous areas, were 
within 1% and 3% for photon and electron plans, respectively. 
Although the beam models were not re-commissioned in 
V13.5, the dosimetric leaf gap (DLG) value was modified and 
the new physical material was added in AXB; as a result the 
dose differences correspond to differences in the dose 
algorithms. Therefore, at field edges and heterogeneity 
interfaces, maximum dose differences increased to 3% and 6% 
for photons and electrons, respectively. Dose calculated 
using AXB was found to be 3% less at the lung interface and 
inside the lung in V13.5 compared to dose calculated in V11, 
but no dose difference calculated using AAA was seen. PO 
could optimize plans 20-30% faster than DVO/PRO. For most 
cases, no significant difference in plan quality was noted. 
However, lung SBRT cases with PO showed a reduction in MUs 
and slightly improved dose conformity. 
 
 
 
 
Conclusion: Commissioning and QA of new TPS version is 
essential prior to clinical release. The tests suggested by 
MPPG provide an excellent framework for this work, 
particularly when combined with additional clinical cases. 
Dose differences noted were chiefly located at beam edges, 
possibly due to modified DLG values, and in heterogeneous 
materials and interfaces using AXB, potentially due to 
differences in material specification. The PO improved 
optimization efficiency in all cases and MU economy and dose 
conformity in some SBRTs, with no reduction in plan quality. 
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Purpose or Objective: Machine Performance Check (MPC) is 
an application to verify geometry and beam performances of 
Truebeam STx , through automated checks . In this 
study,MPC tests were analysed using all photon beam 
energies of our Truebeam STx, comparing whenever possible 
with external independent checks. 
 
Material and Methods: The Machine Performance Check 
(MPC) is a new Truebeam STx major mode, designed to 
evaluate the machines geometric performance. Data 
acquisition comprises a series of 39 images acquired with 
IsoCal Phantom & with particular MLC pattern settings. MPC 
performs geometric and dosimetric checks. The geometric 
checks intend to test the treatment isocenter size and its 
coincidence with imaging devices, the positioning accuracy of 
the imaging systems, collimator, gantry, jaws, MLC leaves & 
the couch position. The dosimetric checks refer to a 
reference MV image and give the beam output, uniformity 
and center change relative to the reference.MPC data were 
acquired during one month on different consecutive days. For 
most of the MPC checks, an independent control has been 
performed at the same time of the acquisition of the MPC to 
evaluate the agreement of the two methods. For the 
independent checks, phantoms and detectors available & 
used routinely in the department were used.The Daily QA3 
was used to check the beam constancy.The first acquisition, 
acquired at the same time as the MPC baseline, was used as 
reference. Also weekly output was performed as per TRS 398 
protocol on water phantom using FC 65 chamber to compared 
with the MPC and Daily QA3 output. 
 
Results: Treatment isocenter was between 0.39 ± 0.02 mm 
with MPC, compared to 0.5 ± 0.01 mm for 6 MV with the 
Winston-Lutz test. Coincidence of kV and MV imaging 
isocenters was within 0.26 ± 0.05 and 0.25 ± 0.06 mm, 
respectively (0.5 ± 0.1 mm with external tests). Positioning 
accuracy of MLC was within 0.5 mm; accuracy of jaws was 
0.12 ± 0.02, 0.14 ± 0.03, −0.77 ± 0.08, 0.11 ± 0.04 mm for X1, 
X2, Y1, Y2 jaws, respectively, with MPC. Dosimetric tests: 
the output stability relative to the baseline for 6 MV .10MV 
and 15 MV was 0.46 ± 0.09%, 0.45 ± 0.08%, 0.3 ± 0.07%for 
MPC compare with 0.82 ± 0.3%, 0.33 ± 0.2%, 0.52 ± 0.33% 
with the independent measurement. 
 
 
 
Conclusion: MPC is a useful tool for QA of Truebeam STx 
systems and its automation makes it highly efficient for 
testing both geometric and dosimetric aspects of the 
machine. Overall, the ability of the MPC to monitor linac 
output stability was comparable to that of ionization 
chamber-based measurements. 
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Purpose or Objective: The purpose of this study is to 
evaluate the sensitivity of ArcCheck 3D diode array to setup 
error for patient-specific quality assurance (QA) of 
volumetric-modulated arc therapy (VMAT). Translational 
setup errors of ± 1, 2 & 3 mm in the RL, SI & AP directions & 
rotational setup errors of ± 0.5°,1◦ & 1.5° in the pitch, roll & 
yaw directions were set up in ArcCheck for 6 patients.The 
pass rate of γ analysis was computed by comparing the 
calculated & measured dose distributions using 3%/3 mm, 
criteria. 
 
Material and Methods: Six VMAT plans for various sites were 
selected for this study. The VMAT plans were designed using 
Eclipse v13 treatment planning system.The ArcCheck 
Dosimetry system consists of 1386 diodes,embedded in the 
cylindrical wall of the phantom with 10 mm spacing. All tests 
were carried out using an Truebeam STx accelerator with a 
high definition MLC . CBCTs were acquired for all the set up. 
Registration between the reference CT and CBCT was carried 
out automatically using an inbuilt rigid registration 
method.The ArcCheck phantom was translated in the right–
left (RL), anterior–posterior (AP), and superior–inferior (SI) 
directions by ± 1,2&3 mm respectively and rotated in the 
pitch, roll, and yaw directions by ± 0.5°,1°& 1.5° using the 
6D treatment couch. To validate the accuracy of perfect 
pitch couch for rotation, smart tool digital level was placed 
on couch to confirm the rotation introduced in phantom. 
Each patient plan were separately delivered on the phantom 
for dose verification in total, 37 measurements (1 without 
positional error, 18 with translational errors, & 18 with 
rotational errors) were performed for each patient.The pass 
rate of γ analysis was computed by comparing the calculated 
and measured dose distributions using 3%/3 mm, criteria 
respectively. 
 
Results: When the translational setup errors are ± 1, 2& 3 
mm, respectively, the pass rates of γ analysis with the 3%/3 
mm criteria decreased by a maximum of 1.7%, 8.4%, and 
11.0% in RL direction; 2.5%, 7.4%, and 12% in the SI direction 
& 2.0%, 7.5%, and 10.5% in the AP direction. When the 
rotational setup errors were ± 0.5°, 1°&1.5°, respectively, 
the pass rates of γ analysis with the 3%/3 mm criteria 
decreased by a maximum of 3.5% ,5% & 12% in the pitch 
direction; 3.2% ,6% & 15.2% in the roll direction,3.5%,8% 
&18% in the yaw direction. 
 
 
 
Conclusion: In this study, ArcCheck diode array showed high 
sensitivity to rotational setup errors. ArcCheck 3D diode array 
is capable of detecting an setup error in order of 1 mm/0.5°. 
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